Heron Share Price

Heron Share Price

NASDAQ: HRTX | Micro Cap | Healthcare
$0.27
-$0.00 (-1.61%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Heron Stock Performance

Open
$0.26
Prev. Close
$0.27
Circuit Range
N/A
Day Range
$0.25 - $0.27
Year Range
$0.25 - $1.56
Volume
47,881
Average Traded
$0.26

Heron Share Price Today

As of 20 November 2026, Heron Therapeutics, Inc.'s share price is $0.27. The stock opened at $0.26, compared to its previous close of $0.27. During today's trading session, Heron Therapeutics, Inc.'s share price traded between $0.25 and $0.27, with an average price of $0.26. Over the past 52 weeks, the stock has recorded a high of $1.56 and a low of $0.25. In terms of performance, Heron Therapeutics, Inc.'s share price has declined by 68.95% over the last six months and is down 76.74% on a year-on-year basis.

Heron Share Price Chart

Line chart of the Heron price trend over the selected period. The price fell overall, ranging from 0.27 to 0.28, ending at 0.27.
$0.25$0.27
L
Show Current Price
H

Heron Stock Fundamentals & Key Indicators

Market Cap
$44.78M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.11
Revenue (TTM)
$154.90B
Return On Equity (TTM)
-438.57%
Profit Margin
-13.04%
Debt to Equity
25.63
Quarterly Earnings Growth YoY
-69.83%

Heron Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$40.59$34.71$37.67$35.25
Net Profit-$2.95-$8.11-$5.49-$5.01
Net Profit Margin-7.27%-23.37%-14.57%-14.21%
Income ChangeN/A-174.92%32.31%8.74%

Heron Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$107.67$127.04$144.29$154.90
Net Profit-$182.02-$110.56-$13.58-$20.20
Net Profit Margin-169.05%-87.03%-9.41%-13.04%
Income ChangeN/A39.26%87.72%-48.75%

Heron Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets17.8124.1333.7345.52
Current Assets238.07209.01188.77205.44
Total Assets255.88233.15222.51250.95
Non Current Liabilities145.45175.34176.79155.02
Current Liabilities96.191.4679.6982.36
Total Liabilities241.54266.8256.48237.38
Shareholders' Equity14.33-33.65-33.9713.57

Heron Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-27.59-22.53-58.79-146.91
Investing16.0118.7118.0-3.32
Financing14.430.9454.1175.06

About Heron

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Heron Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.28
$0.26
-5.40%
Oct 2026
$0.32
$0.28
-13.12%
Sep 2026
$0.32
$0.32
-3.61%
Aug 2026
$0.50
$0.33
-33.33%
Jul 2026
$0.43
$0.50
+16.63%
Jun 2026
$0.88
$0.43
-50.64%
May 2026
$1.22
$0.86
-28.22%
Apr 2026
$0.81
$1.21
+51.38%
Mar 2026
$1.18
$0.80
-33.67%
Feb 2026
$1.32
$1.20
-9.43%
Jan 2026
$1.30
$1.32
+2.32%
Dec 2025
$1.14
$1.29
+12.12%

Heron Share Price FAQs